Journal
/
/
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
JoVE Journal
İmmünoloji ve Enfeksiyon
Bu İçerik görüntülemek için JoVE aboneliği gereklidir..  Oturum açın veya ücretsiz deneme sürümünü başlatın.
JoVE Journal İmmünoloji ve Enfeksiyon
Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics (DCAF)
DOI:

09:39 min

September 17, 2019

, , , , , ,

Bölümler

  • 00:05Başlık
  • 00:57Chemical Synthesis of the Hydrazine Derivative of a Fc-III Peptide
  • 02:31Cleavage of the SUMO Tag
  • 04:09Assembling of DCAF1 by Native Chemical Ligation
  • 07:06Mass Spectrometry and ELISA Assay
  • 08:19Results: Native Chemical Ligation and ELISA Assay
  • 09:03Conclusion

Summary

Otomatik Çeviri

Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) is novel for the elimination of harmful antibodies. Here, we describe a detailed protocol for the synthesis of DCAF1 molecule, which can selectively block 4G2 antibody to eliminate antibody dependent enhancement effect during Dengue virus infection.

İlgili Videolar

Read Article